Favipiravir effectiveness in patients undergoing COVID19 Acute respiratory distress syndrome (ARDS)
Phase 3
- Conditions
- covid positive.Coronavirus infection, unspecifiedB34.2
- Registration Number
- IRCT20150107020592N26
- Lead Sponsor
- Masih Daneshvari Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Positive covid patients
Patients with a pao2 to fio2 ratio below 300
Age over 18 years
Exclusion Criteria
Lack of desire to enter the plan
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Oxygenation. Timepoint: Up to 10 consecutive days. Method of measurement: pulse Oximetry.
- Secondary Outcome Measures
Name Time Method Mortality. Timepoint: Completion of treatment. Method of measurement: death.